Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hip implant shows promise in 10-Year study

NCT ID NCT02648152

First seen Jan 23, 2026 · Last updated Jun 24, 2026 · Updated 19 times

Summary

This study followed 218 people who received a cementless POLARSTEM hip implant to treat osteoarthritis. Researchers tracked how well the implant worked and how long it lasted over up to 10 years. The goal was to see if this implant is a safe and effective option for hip replacement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Kantonsspital Aarau, Orthopedics

    Aarau, 5001, Switzerland

  • St. Elisabeth Hospital, Orthopedics and Rheumatology

    Bochum, 44787, Germany

  • University Marburg, Orthopedics and Rheumatology

    Marburg, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cementless POLARSTEM hip implant

What this could lead to

If successful, this could confirm that the POLARSTEM implant is a reliable, long-lasting option for hip replacement in people with osteoarthritis.

What could go wrong

This is an observational study, not a controlled trial, so results may not apply to all patients. Some implants may fail or require revision over time.

Conditions

The condition(s) this trial relates to.

osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.